Priority Review of Drug Submissions (Therapeutic Products) (English, HTML)

View metadata and access the original English HTML file: Priority Review of Drug Submissions (Therapeutic Products).

Format

HTML

Access

file-only

Publisher-reported update

2023-09-03

Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of a request submitted by the sponsor of the drug. Priority Review submissions are introduced into Health Canada's drug review queue in accordance with an accelerated review target of 180 days.

Access original file